Shares in the U.K.-based drug giant fell sharply Thursday after an news outlet in Israel reported late Wednesday that he was moving to lead Teva Pharmaceuticals Ltd., an Israeli generics drugmaker that has been looking for a new chief for months. AstraZeneca and Teva declined to comment.
from WSJ.com: US Business http://ift.tt/2sTa8hv
via IFTTT
No comments:
Post a Comment